TD Waterhouse Canada’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,000
Closed -$3.42K 2078
2025
Q2
$3.42K Hold
2,000
﹤0.01% 1663
2025
Q1
$2.82K Hold
2,000
﹤0.01% 1646
2024
Q4
$3.04K Hold
2,000
﹤0.01% 1643
2024
Q3
$3.7K Hold
2,000
﹤0.01% 1552
2024
Q2
$3.48K Hold
2,000
﹤0.01% 1564
2024
Q1
$4.68K Hold
2,000
﹤0.01% 1550
2023
Q4
$3.66K Hold
2,000
﹤0.01% 1424
2023
Q3
$1.91K Hold
2,000
﹤0.01% 1500
2023
Q2
$2.22K Hold
2,000
﹤0.01% 1530
2023
Q1
$1.3K Hold
2,000
﹤0.01% 1566
2022
Q4
$1.43K Hold
2,000
﹤0.01% 1525
2022
Q3
$1.4K Hold
2,000
﹤0.01% 1546
2022
Q2
$4.12K Hold
2,000
﹤0.01% 1431
2022
Q1
$7K Hold
2,000
﹤0.01% 1397
2021
Q4
$9.42K Buy
+2,000
New +$10.8K ﹤0.01% 1346

Other funds holding CGEN

TD Waterhouse Canada's CGEN Position: Q3 2025 in Review

TD Waterhouse Canada sold out of Compugen (CGEN) in Q3 2025, closing a stake of 2,000 shares — an estimated $3.42K sold.

TD Waterhouse Canada first reported a position in CGEN in Q4 2021 and held it in 15 quarters. The position peaked at $9.42K in Q4 2021. 69 funds tracked by Wall St. Rank hold CGEN as of Q3 2025.

  • TD Waterhouse Canada reported no remaining Compugen position as of Q3 2025 after selling out during the quarter.
  • TD Waterhouse Canada sold 2,000 Compugen shares in Q3 2025, an estimated $3.42K.
  • TD Waterhouse Canada first reported a position in Compugen in Q4 2021 and held it in 15 quarters.
  • TD Waterhouse Canada's Compugen position peaked at $9.42K in Q4 2021.
  • 69 funds tracked by Wall St. Rank held Compugen as of Q3 2025.

Based on TD Waterhouse Canada's 13F filing for Q3 2025, filed 3 Nov 2025.